Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acid Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel acidified silica gel method for dabigatran intermediate. Reduces waste, improves purity, ensures supply chain stability for pharma manufacturing.
Novel three-step synthesis of Paeoveitol overcomes natural isolation limits ensuring stable supply and cost efficiency for pharmaceutical intermediate manufacturing partners.
Patent CN107163000B reveals a green one-pot synthesis method for Clothianidin using phosphotungstic acid, ensuring high purity and significant cost reduction in agrochemical intermediate manufacturing.
Patent CN109824562A reveals a green lactic acid catalyzed route. Achieve high purity and cost reduction in fine chemical manufacturing with scalable processes.
Patent CN109824562A reveals ultrasonic lactic acid catalysis for high-purity intermediates. Offers significant cost reduction and supply chain reliability for global buyers.
Patent CN107311868B details a green esterification method offering high purity and recyclable catalysts for scalable pharma intermediate manufacturing and supply chain efficiency.
Patent CN107311868B details a green resin catalyst method for methyl p-tert-butylbenzoate ensuring high purity and reduced corrosion for reliable supply chains.
Novel sulfonic acid resin catalyzed esterification ensures high purity and reduced corrosion for reliable methyl p-tert-butylbenzoate supply chain optimization.
Patent CN112811986A reveals a dual-acid catalytic route for triaryl ethylenes. This method offers high stereoselectivity and mild conditions for pharmaceutical intermediates.
Discover a novel Ezetimibe synthesis method using titanium Lewis acids. Achieve high purity and cost reduction in pharmaceutical manufacturing with scalable routes.
Patent CN101395140B reveals a high-yield process for 2-imidazolidinones using solid acid catalysts and hydrogenation, offering significant cost and safety advantages for pharmaceutical intermediate manufacturing.
Patent CN104402814A details a one-pot synthesis reducing waste. We offer high-purity agrochemical intermediates with scalable, cost-effective manufacturing solutions.
Patent CN110835639A reveals a dual-enzyme DKR process for high-purity (S)-tetrahydroisoquinoline derivatives, offering superior ee values and scalable manufacturing for pharmaceutical intermediates.
Patent CN102432628A reveals a one-pot synthesis for Cefonicid intermediate BP1, eliminating boric acid filtration and boosting yield to 99%.
Patent CN110317849B reveals a high-yield enzymatic method for producing chiral tetrahydroisoquinoline intermediates, offering significant cost and purity advantages for pharmaceutical manufacturing.
Patent CN1837168A details a novel SnCl4-catalyzed synthesis of 1,3,5-triphenylbenzene, offering high purity for OLED materials and significant cost reduction in electronic chemical manufacturing.
Patent CN102516139A details a green synthesis of phenylene sulfides using ionic liquids and solid superacids, offering high purity and cost reduction in fine chemical manufacturing.
Patent CN1166628C reveals a novel AlCl3-ZnCl2 catalytic route for N,N-dicyanoethyl arylamine, offering higher yields and lower energy consumption for dye manufacturers.
Patent CN114890999B reveals a 5-step PQQ synthesis with 39% yield. Discover cost reduction and supply chain advantages for pharmaceutical intermediates manufacturing.
Discover a novel synthetic route for Tolterodine intermediates utilizing safe borohydride reduction. This patent-based analysis highlights significant cost reduction and scalable manufacturing advantages for pharmaceutical supply chains.